Engineered Connectivity from operating companies Bulgin, L-com, Pasternack, Transtector, PolyPhaser, Capable and KC Industrie address industrial, AI and energy applications 

MUNICH, Oct. 29, 2026 /PRNewswire/ — Infinite Electronics, a global manufacturer of specialized connectivity solutions, will exhibit at electronica 2026 in Munich, 10–13 November. Visitors to Infinite Electronics’ booth in Hall A3, Stand 241 will see connectivity products for data centre, drone, industrial automation and energy applications from its operating companies, including Bulgin, L-com, Pasternack, Transtector, PolyPhaser, Capable and KC Industrie. 

“Our customers face complex requirements that require solutions spanning multiple product categories, and our engineering expertise and product offering means we can partner with them throughout the processes,” said Nick Young, President & General Manager of Infinite Electronics’ Industrial & ICC Business Units. “A drone programme, for example, needs antennas, sealed connectors and surge protection. Most engineers have to source them from three suppliers. We have Pasternack antennas, Bulgin connectors and Transtector surge protection, so with Infinite it’s one conversation with experts who operate as a true technology partner in developing the solution.” 

At the booth, visitors can experience product demonstrations, speak directly with industry experts, and explore high-performance connectivity solutions built for demanding applications. An interactive display will showcase products using RF tags that automatically trigger relevant information on overhead screens, while touchscreens across the stand provide detailed technical specifications. 

The stand will feature Bulgin’s new hybrid circular connectors, which are part of its 6000 Series Buccaneer range. These solutions can be configured with two, four or six contacts, combining power and signal connectivity in a single rugged connector. Additional products in the exhibit will include: 

Visit Hall A3, Stand 241 to meet with Infinite Electronics experts and explore solutions for specific application needs. 

To learn more about Infinite Electronics’ connectivity solutions, visit www.InfiniteElectronics.com. 

About Infinite ElectronicsInfinite Electronics powers a global portfolio of specialized connectivity companies that design, manufacture and deliver reliable engineered solutions worldwide. Built as a unified platform for speed, scale and reliability, the company combines shared infrastructure, best-in-class logistics and deep engineering expertise to support mission-critical connectivity needs. Through scalable global operations and rapid development capabilities, Infinite helps customers accelerate innovation and bring new ideas to market. Learn more at www.infiniteelectronics.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/infinite-electronics-showcases-engineered-connectivity-solutions-at-electronica-2026-302922830.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Una nuova ricerca di Rockwell Automation analizza gli ostacoli tra l’adozione dell’AI e i risultati di business misurabili 

MILWAUKEE, 28 ottobre 2026 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), la principale azienda mondiale dedicata all’automazione industriale e alla trasformazione digitale, ha pubblicato oggi nuove analisi che esaminano come i produttori di alimenti e bevande possano superare la fase dei singoli progetti pilota di intelligenza artificiale e ottenere risultati di business misurabili su larga scala. Basata sui risultati del report “State of Smart Manufacturing 2026” di Rockwell Automation, l’analisi evidenzia le sfide legate ai dati, alla tecnologia e alle competenze del personale che le aziende devono affrontare per tradurre gli investimenti in AI in benefici concreti a livello aziendale. 

L’adozione dell’AI sta accelerando in tutto il settore dell’industria alimentare. Secondo il rapporto “State of Smart Manufacturing 2026”, quasi il 90% delle aziende manifatturiere del settore food and beverage sta già utilizzando l’AI e il machine learning o prevede di farlo nel prossimo futuro. Allo stesso tempo, le aziende manifatturiere dichiarano di utilizzare efficacemente solo il 45% circa dei dati che raccolgono, un limite significativo alla possibilità di estendere le iniziative di AI su larga scala e sfruttarne appieno il potenziale. 

“Molte aziende manifatturiere hanno ormai superato la fase in cui si chiedevano se l’AI potesse apportare valore”, ha affermato Greg Schmidt, Vice President, CPG Global Industry, Rockwell Automation. “L’attenzione ora si concentra su come estendere i progetti pilota di successo all’intera organizzazione. Ciò richiede più che nuova tecnologia. Richiede dati connessi, processi operativi integrati e un chiaro collegamento tra le iniziative di AI e i risultati di business.” 

I risultati evidenziano come le aziende che ottengono il maggior successo con l’AI siano quelle che la considerano parte di una più ampia strategia di trasformazione digitale. Anziché concentrarsi su casi d’uso a sé stanti, investono in una maggiore integrazione tra i sistemi operativi e aziendali, migliorano l’accessibilità dei dati e allineano le iniziative di AI a obiettivi strategici quali il miglioramento della qualità, l’aumento della produttività, la riduzione dei costi e la minimizzazione dei rischi. 

L’analisi sottolinea inoltre la crescente importanza dell’integrazione IT/OT con l’espansione dell’utilizzo dell’AI.  Secondo le previsioni degli intervistati la quota dei processi produttivi supportati dall’AI passerà dall’attuale 37% circa a oltre il 60% entro il 2030, rendendo sempre più importante la disponibilità di dati connessi e contestualizzati. 

Oltre agli aspetti tecnologici, la ricerca individua nelle competenze e nella preparazione della forza lavoro un fattore determinante per il successo a lungo termine. Il report rileva che il 93% delle aziende manifatturiere prevede che le iniziative di smart manufacturing trasformeranno la propria forza lavoro, mentre il 40% dichiara di aver investito nella riqualificazione dei dipendenti nel corso dell’ultimo anno. Le organizzazioni che riescono ad allineare persone, processi e tecnologia si trovano generalmente in una posizione più favorevole per innovare e sostenere i risultati nel tempo. 

Il documento completo di domande e risposte, Dai progetti pilota di AI all’impatto aziendale: come i produttori di alimenti e bevande possono estendere l’uso dell’AI per ottenere risultati di business misurabili, è disponibile a questo [LINK]. 

Domande frequentiPerché i produttori di alimenti e bevande incontrano difficoltà nell’estendere l’utilizzo dell’AI oltre i progetti pilota? 

Sebbene l’adozione dell’IA sia diffusa, molte organizzazioni non dispongono ancora di dati connessi, processi standardizzati e sistemi integrati necessari per estendere su larga scala le iniziative di successo. I produttori di alimenti e bevande dichiarano di riuscire a utilizzare efficacemente solo il 45% circa dei dati che raccolgono, limitando la capacità dell’AI di generare risultati concreti a livello aziendale. 

Perché la connettività dei dati è così importante per il successo dell’AI? 

L’AI può generare analisi significative solo quando ha accesso a dati contestualizzati e di alta qualità. Le aziende manifatturiere che integrano i sistemi operativi e aziendali possono migliorare la visibilità sui processi, superare i silos informativi e consentire all’AI di supportare un processo decisionale più rapido e informato. 

Quali risultati di business intendono ottenere le aziende manifatturiere attraverso l’AI? 

I produttori di alimenti e bevande sono sempre più focalizzati su risultati misurabili, tra cui il miglioramento della qualità, l’aumento della produttività, la riduzione dei costi e il contenimento dei rischi operativi. Le organizzazioni che allineano le iniziative di AI a questi obiettivi sono generalmente in una posizione migliore per dimostrare il ritorno sull’investimento e ottenere il sostegno necessario a un’implementazione su più ampia scala. 

Cosa distingue le aziende manifatturiere che implementano con successo l’AI su vasta scala? 

Le organizzazioni leader considerano l’AI come parte di una più ampia strategia di trasformazione piuttosto che come un insieme di singoli progetti. Stabiliscono solide basi per la gestione dei dati, integrano i sistemi IT e OT, definiscono processi replicabili e investono nello sviluppo delle competenze del personale per favorire un’adozione duratura dell’AI e generare risultati concreti per il business. 

Informazioni su Rockwell AutomationRockwell Automation, Inc. (NYSE: ROK) è leader mondiale nell’automazione industriale e nella trasformazione digitale. Connettiamo l’immaginazione delle persone al potenziale della tecnologia per espandere ciò che è umanamente possibile, rendendo il mondo più produttivo e più sostenibile. Rockwell Automation, con sede a Milwaukee, Wisconsin, conta circa 26.000 dipendenti impegnati a supportare i nostri clienti in oltre 100 Paesi, secondo i dati di fine anno 2025. Per saperne di più su come stiamo realizzando la Connected Enterprise nelle imprese industriali, visitate il sito www.rockwellautomation.com. 

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/i-produttori-di-alimenti-e-bevande-puntano-a-estendere-lutilizzo-dellai-oltre-la-fase-pilota-302922775.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Utilization of geothermal industrial heat in these locations could displace over 850 million euros per year in fuel spending, increase energy security on the continent, and avoid 4.3 million tonnes of carbon dioxide emissions annually 

MADRID, Oct. 28, 2026 /PRNewswire/ — Project InnerSpace, in partnership with Future Cleantech Architects (FCA), released today Unlocking Europe’s Geothermal Industrial Heat Potential, a first-of-its-kind analysis identifying geothermal potential in every European Union (EU) country and highlighting 30 industrial clusters across 11 European countries that are priority candidates for geothermal heat conversion. 

Together, the clusters could displace over €850 million a year in fuel spending, and avoid 4.3 million tonnes of carbon dioxide emissions annually – equivalent to CO₂ emissions from more than nine million barrels of oil consumed. 

The 30 opportunities are located in 11 Member States: Austria, Belgium, Bulgaria, France, Germany, Hungary, Italy, the Netherlands, Poland, Slovakia, and Spain. 

The 30 identified clusters are a starting point, not the limit of the opportunity: the analysis also identifies a wider pool of 152 candidate clusters that could follow, with every country in the EU having potential for geothermal industrial heat utilization. 

Natural gas supplies roughly half of EU industrial heat, and the EU imports about 90% of the gas it consumes. Yet the subsurface beneath the EU 27 holds an estimated 18,000 gigawatts-thermal of heat at 100°C or above, a temperature sufficient to service a wide variety of industrial heat processes, including cooking, dehydration, distillation, and sterilization. 

Geothermal, often overlooked in heat decarbonization discussions, could provide Europe with reliable, domestic, always-on heat while reducing exposure to imported fuels and volatile energy prices. A spike in gas prices on the continent in 2022 illustrated how exposed European industry is to imported fuel volatility, with output in Germany’s energy-intensive industries falling by about 20% as one example. Drawing more industrial heat from domestic geothermal wells could reduce that exposure to price swings and supply disruptions, and help European manufacturers stay competitive. 

“Geothermal is often thought of as electricity, but its industrial heat applications are a major opportunity hiding in plain sight,” said Drew Nelson, VP of Strategy at Project InnerSpace. “Europe has enormous potential for geothermal industrial heat. Utilizing it can strengthen Europe’s energy security and industrial competitiveness at a time of high energy prices.” 

The analysis proposes the following policy interventions to support geothermal industrial heat utilization: 

“Next-generation geothermal has great potential but is still in the early phases of commercialization in Europe. It is precisely at this point that public policy can bridge the gap between the lab and the market – just as it did for solar and wind decades ago,” said Dr Marlène Siméon, Director of Policy at Future Cleantech Architects. 

The EU’s forthcoming Geothermal Strategy and Action Plan, together with the Geothermal Stakeholder Partnership, is a natural place to bring these measures together by naming priority clusters for geothermal in industrial heat development. Member States can spell out the role geothermal will play in meeting renewable energy targets in their national energy and climate plans. The 30 clusters give both levels of government a practical place to begin. 

Project InnerSpace and Future Cleantech Architects will present the findings in a webinar on
October 28, with opening remarks from Andris Piebalgs, former EU Commissioner for Energy, and Martin Hojsík, European Parliament Vice-President. 

The report can be found here: https://projectinnerspace.org/info/unlocking-europes-geothermal-industrial-heat-potential
 

About Project InnerSpace 

Project InnerSpace is the leading independent non-profit organization dedicated to the global development of geothermal energy. We are a focused research organization, on a mission to remove the major barriers standing in the way of the exponential growth and development of geothermal energy worldwide by 2030. To learn more about Project InnerSpace, please visit www.projectinnerspace.org. 

About Future Cleantech Architects 

Future Cleantech Architects is an independent, non-profit, and non-partisan climate think tank focused on accelerating innovation in critical industries to close the gap to net-zero by 2050.  

View original content:https://www.prnewswire.com/news-releases/new-analysis-identifies-30-european-industrial-clusters-as-top-candidates-for-geothermal-heat-conversion-302922576.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

LONDON, Oct. 28, 2026 /PRNewswire/ — Inspired Thinking Group (ITG)’s Storyteq marketing platform has been named a Leader in the Gartner® Magic Quadrant™ for Digital Asset Management for the third year in a row. 

Storyteq’s sustained recognition follows the rapid enterprise adoption of its advanced Halo Intelligence® capabilities, with the platform recommending the best and most relevant marketing assets for every target audience and scenario. 

Another popular Storyteq innovation is AgentConsole™, enabling brands to unify and control every AI agent in a single, robustly governed system. With AgentConsole™, organizations can rapidly deploy AI agents within a governed environment, enabling powerful content operations and orchestrating end-to-end workflows at scale. 

“The reason Storyteq is outstripping legacy platforms is down to how we treat artificial intelligence,” says Andrew Swinand, ITG CEO. “While many companies approach AI as a series of disconnected features, we have engineered a completely unified, agentic content operating system. Storyteq makes AI part of how work gets done every day. 

“I believe this is reflected in once again being named a Gartner® Magic Quadrant™ Leader in the highly competitive DAM space, and the credit goes to our teams for their outstanding work and unwavering commitment to innovation.” 

Through AgentConsole™, Storyteq deploys coordinated, brand-safe teams of agents that handle everything from compliance checking and workflow orchestration to real-time visual verification of brand guidelines. 

And when combined with Halo Intelligence, the platform actively tells the marketer which assets are working, why they are working, and how to dynamically adapt them to drive immediate ROI across every channel. 

“We are not just building a DAM to help people create and find content faster,” adds Swinand, “We are delivering an open, AI-agnostic infrastructure that governs the entire content lifecycle.” 

Earlier this year, Storyteq was also recognized as a Leader in the Gartner® Magic Quadrant™ for Content Marketing Platforms (CMP), positioned higher than any other platform on the Ability to Execute axis. It was the fourth consecutive year that Storyteq was placed as a CMP Leader. 

Both Storyteq DAM and Storyteq CMP are built on the same core architecture, so organizations who license both enjoy a seamless single-platform experience that unifies governance and creative activity from upstream strategy and workflows to asset management and deployment. 

According to ITG Chief Strategy Officer John Kirk, “Governance remains a blocker for organizations implementing AI solutions. Legacy platforms simply cannot contain the risk, but Storyteq is designed to act as a central coordinator, instantly checking every automated action against locked brand rules while tracking the entire asset history in a secure, unalterable log. 

“We are giving global enterprises the infrastructure to scale content automation rapidly without losing brand or regulatory control.” 

A core Storyteq capability remains its endless configurability and scalability, enabling it to offer worldwide enterprise support by meeting the unique needs of every business, no matter how many users, brands, and markets it has. 

Developed to connect and work seamlessly with adjacent platforms, Storyteq DAM unifies all global enterprise activity and corporate data into a single source of truth. 

Objectivity DisclaimerGartner, Magic Quadrant for Digital Asset Management Platforms, by Rene Cizio, Tia Zervas & Karen Lee, 26th October 2026 

Gartner and Magic Quadrant are trademarks of Gartner, Inc., and/or its affiliates. 

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/itgs-storyteq-named-a-gartner-leader-in-dam-on-the-back-of-advanced-approach-to-ai-302922552.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Key Takeaways 

CONSHOHOCKEN, Pa., Oct. 28, 2026 /PRNewswire/ — Suvoda, a clinical trial technology company, today announced new capabilities in Greenphire Travel, its software and services dedicated to removing the logistical barriers that keep patients from participating in trials. Travel remains one of the most significant logistical barriers to clinical trial enrollment and retention. For example, in the most recent CISCRP study, among participants who found their study disruptive, 49% cited travel to the study clinic as a cause. Suvoda’s latest product release includes enhancements that aim to lower these barriers. 

Greenphire Travel now gives sponsors and CROs more choice in travel support, greater visibility into travel costs and trip status, and simpler travel for their patients. 

“Participants in clinical trials are often managing serious illness on top of the logistical demands of getting to visits. Greenphire Travel removes the coordination burden from sites and their patients so they can focus on what matters—their health and wellbeing,” said Elizabeth Smith, Director of Product Management, Patient Experience at Suvoda. 

More rideshare access for participants, more control for sites and sponsors 

Greenphire Travel now offers global rideshare and car services, with Lyft, Uber Health, and Bolt available to participants and sites depending on region. Participants can book eligible rides through the Suvoda App and view details regarding flights, hotels, rideshare status, study appointments, questionnaires, and payments. This reduces routine status inquiries routed through site staff and gives participants more direct control over their trial experience. 

Sites get a more intuitive travel request workflow, a clearer view of trip status, and secure messaging. Sponsors and CROs gain more detailed reporting for better visibility into travel spend and policy across global trials. 

“As clinical trial travel grows more complex, sponsors and sites need connected, actionable insight across the study,” said Will Wing, Director of Product at Suvoda. “This release brings real-time trip status, consolidated reporting, and clearer cost information together into one streamlined experience. That’s the value of a platform approach.” 

Sponsors choose the travel support model that fits each study 

Greenphire Travel provides expert global support services, available through two distinct delivery models. A site-led option allows study teams to easily initiate straightforward travel requests directly, while the Concierge model provides high-touch, personalized coordination for more complex studies and participant needs. Concierge coordinators are stationed across 40+ countries, each available 24/7 to support participants for the duration of a trial. 

“Clinical trials vary enormously in complexity, and the travel support behind them should too,” said Wing. “Sponsors can choose the level of service that fits each study or site rather than applying a single model across their entire portfolio. For patients in oncology or rare disease especially, that difference can be significant.”  

Frequently Asked Questions 

Q: Where is Greenphire Travel available? 

A: Greenphire Travel delivers services globally and has supported more than 8,400 sites across 2,000+ trials in over 50 countries. Rideshare access through Lyft, Uber Health, and Bolt is now available to participants and sites in multiple regions. Concierge coordinators are stationed across 40+ countries to provide 24/7, localized, native-language support. 

Q: Do patients or sites have to pay for travel costs upfront? 

A: No. Greenphire Travel is designed so that patients, caregivers, and sites have $0 out-of-pocket costs for covered travel services. Eligible travel is funded upfront by the sponsor and managed through Suvoda, removing reimbursement delays and financial stress for participants and sites. 

Media ContactRobin AbadíaDirector, External Communications, Suvodamarketing@suvoda.com
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/suvoda-helps-patients-stay-in-trials-with-more-travel-choice-and-control-through-expanded-greenphire-travel-302919190.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

NIIGATA, Japan, Oct. 28, 2026 /PRNewswire/ — Located in Yuzawa, Niigata Prefecture, the ski area offers 45 courses, hot springs, local sake, and regional cuisine, just 71 minutes from Tokyo by Shinkansen. 

YUZAWA SNOW LINK, connecting Yuzawa Kogen, GALA Yuzawa, and Ishiuchi Maruyama in Yuzawa, Niigata Prefecture, will open for the 2026–2027 winter season on Saturday, December 26, 2026. 

Official website: https://www.yuzawasnowlink.com/winter/en/
 

The three resorts offer ski courses for all skill levels, from beginners to advanced skiers. Visitors can also enjoy snow-covered mountain scenery, historic hot springs, locally produced sake, and regional cuisine featuring Niigata-grown rice and other local ingredients. 

1. Easy Access from Tokyo by ShinkansenYuzawa is an accessible winter destination from Tokyo. GALA Yuzawa Station can be reached in as little as 71 minutes by the Joetsu Shinkansen, making the area suitable for both day trips and overnight stays. Visitors can combine skiing or snowboarding with sightseeing in the surrounding area. 

2. Three Resorts Offering Varied Courses and SceneryYUZAWA SNOW LINK connects Yuzawa Kogen, GALA Yuzawa, and Ishiuchi Maruyama. Each resort offers its own mountain scenery and courses with varying levels of difficulty, providing options for visitors with different interests and skiing or snowboarding experience. 

Beyond winter sports, visitors can enjoy the region’s snow-covered mountain landscapes. 

3. Hot Springs and Local Cuisine Beyond the SlopesYuzawa is home to a historic hot spring district where visitors can relax before or after a day on the slopes. The area also offers regional cuisine prepared with Niigata-grown rice and local ingredients, as well as locally produced sake. 

Whether visiting for a day or staying longer, travelers can combine skiing and snowboarding with hot springs, dining, and sightseeing for a well-rounded winter getaway. 

About YUZAWA SNOW LINKYUZAWA SNOW LINK connects three ski resorts: Yuzawa Kogen, GALA Yuzawa, and Ishiuchi Maruyama. For operating schedules, lift tickets, and information on connections between the resorts, please visit their official websites. 

Official WebsitesYuzawa Kogen Ski Resort: https://www.yuzawakogen.com/GALA Yuzawa Ski Resort: https://gala.co.jp/  Ishiuchi Maruyama Ski Resort: https://ishiuchi.or.jp/en/winter/
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/yuzawa-snow-link-connecting-three-ski-resorts-to-open-for-the-20262027-winter-season-on-december-26-302920651.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

PARIS, Oct. 28, 2026 /PRNewswire/ — From 22 – 23 October, the Cabinet Office, Government of Japan, hosted Lineage of Gold * Lineage of Silver, an exclusive exhibition of Japanese artistry from the Sui Collection at the Palais de Chaillot in Paris. The event welcomed over 300 guests from across Europe’s luxury, business, political, cultural, and creative sectors, as well as established collectors. 

The exhibition, curated by renowned author and cultural producer Mari Hashimoto, presented Japanese traditional crafts through a contemporary presentation that showcased gold and silver, two highly valued metals that each have very distinct qualities. 

Bringing together treasured objects sourced from across Japan, the works on view in Lineage of Gold * Lineage of Silver span gallery representation and institutional collections to the archives of traditional craft workshops, reflecting the practices and traditions that contribute to Japan’s rich cultural landscape and history. 

Around 60 examples of Japanese art and craftsmanship were on display. The exhibition included lacquerware, metalwork, ceramics, textiles and sword-making. Lineage of Gold * Lineage of Silver revealed lesser-known techniques and traditions such as kirikane (a decorative technique used for Buddhist statues and paintings, using gold and silver leaf) and kinkarakami (a gilded embossed technique). 

Guests were drawn to the textile, ceramics and the gold leaf works, and to objects which were crafted employing a particularly complex technique. Among these were the Kumihimo-Nara-gumi cords by Dōmyō. Among the many techniques used to create cords are twisting, braiding, weaving, and forms of concealed stitching. 

Elsewhere, the embroidered obi belts by Kondaya Genbei also proved to be popular. Rooted in ancient traditions of binding the body and the Shinto concept of Yorishiro, the obi has been considered as a vessel for divine presence, and Kondaya Genbei preserves this legacy through innovative materials and artistry. 

Alongside historical works, guests were also drawn to more contemporary pieces, such as the Remnant: Stone by Terumasa Ikeda. The ethereal work composed of shimmering shell inlays with delicate, laser-cut numbers and lines on ultra-thin lacquer surfaces blends traditional Japanese raden craftsmanship with futuristic, digital-inspired motifs. 

Guests were treated to a range of Japanese culinary delicacies including kombu-cured yellowtail sashimi and caviar hosomaki sushi roll created by the renowned contemporary restaurant L’Abysse Paris, overseen by Yannick Alléno, a leading figure in modern French gastronomy, and Yasunari Okazaki, an innovative Japanese sushi chef. 

The works were illuminated through an evocative light art installation by acclaimed lighting designers Akari-Lisa Ishii and Motoko Ishii, transformed the gallery space titled La Cathédrale and revealed the objects through a careful juxtaposition of shadow and atmosphere. 

Masaya Kitao, Councillor, Cabinet Secretariat, gave a speech on behalf of the Government of Japan, saying: “JAPAN SUI COLLECTION is more than a showcase of exquisite creations. It is a journey to discover the beauty and elegance that lie hidden across Japan, and to bring new forms of value into being together with you. The traditional crafts and cuisine you see and experience today represent but a small part of that rich inheritance. The story of a Japanese craft truly begins when it is placed in the hands of someone who understands it. Each owner adds a new chapter to its history. In this way, the object itself can become a source of new value. It is also our responsibility to preserve and pass on the spirit and craftsmanship of these traditions, allowing them to resonate with other cultures and find new expressions of harmony without losing their essence.” 

Guests were captivated by a performance by renowned Japanese dancer Min Tanaka, known for his original dance works that explore the body and movement through improvisation. 

The Sui Collection is an initiative of the Cabinet Office, Government of Japan, which aims to present outstanding Japanese artistry and distinctive creations from across the country. https://japan-sui-collection.go.jp/  

Coming Soon: JAPAN SUI COLLECTION in KYOTO 

Dates: 7 – 8 November 2026Venue: Kyoto State Guest House, Kyoto, Japan (invitation only)Hosted by: Cabinet Office, Government of Japan 

To access the full media kit and further images please use this link: HERE
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/japan-sui-collection-paris-presents-lineage-of-gold–lineage-of-silver-2223-october-2026-302922234.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Research points to trust as the real barrier to scaling agentic AI, with 58% saying the industry still lacks clear standards for responsible AI 

TORONTO and NEW YORK, Oct. 28, 2026 /PRNewswire/ — Life sciences organizations are putting governance in place to scale agentic AI across commercial, medical, and patient-facing work, according to the Responsible AI in Life Sciences (RAIL) Report 2026. The new industry research is based on roundtables and a survey of senior leaders at pharmaceutical, biotech, and medical device companies. Two-thirds (64%) surveyed say their organization has an AI governance process either fully established or in development. 

The research, from 
ACTO, finds an industry ready to use AI but still working to trust it. Governance is the AI concern leaders cite most often. It is also the one they admit they have most neglected in practice. More than one-third still either have no defined governance or rely on a one-time IT approval. 

Trust is the barrier to adoption at scale 

The findings suggest trust will decide how far and how fast life sciences scales AI. Technology no longer appears to be the main obstacle. Leaders rank regulatory, legal, or compliance hesitation (21%) as the biggest internal barrier to scaling AI, while technical readiness ranks near the bottom (9%). Asked which measure matters most when judging an AI pilot, leaders put trust and adoption (24%) ahead of efficiency (23%), a signal that expectations are evolving. 

Leaders trust AI more in their own hands than in their organizations’. More than two-thirds of leaders (68%) are involved in an AI project at their organization, and 69% rate their personal comfort with AI as high. But more than half (54%) remain concerned about how AI is being used in their own organizations. Fifty-eight percent say life sciences has no clear industry standard for responsible AI. 

“The discussions reflected a wide range of perspectives and experiences related to AI understanding, adoption, and oversight across the industry,” said Lisa DeMarco, general counsel and chief business officer at Arctic Therapeutics and a moderator at the RAIL roundtables hosted by ACTO. “An important theme in the conversations was the need for practical guidance to help organizations assess AI trustworthiness while maintaining a focus on patient safety.” 

Governance builds the foundation for trust 

Leaders described governance as an ongoing operating model that continues well past initial approval. It needs named business owners, clear escalation paths, and standard operating procedures (SOPs), as well as the ability to deploy and revoke an AI agent and governance enforced at both the agent and sub-agent level. A challenge is that ownership is still unsettled. Asked who should be held ultimately accountable for the actions an AI agent takes, leaders name the end user (34%), legal and compliance (28%), the third-party AI vendor (22%), and IT (16%). 

The data suggests responsibility falls to the end user because so much AI use happens outside approved systems. Nearly a quarter of organizations (23%) don’t monitor or discuss employee use of unauthorized AI agents, and roundtable leaders described employees already building their own agents with no governance in place. The gap between AI adoption and AI oversight is where trust seems to be breaking down across the industry. 

Industry quickly moving from where to start to what to build next 

Leaders want AI to raise performance and to be judged fairly. Four in five (79%) agree AI risk and ROI should be measured against how people do the work today, with its own error rate. Improved results and outcomes (29%) ranked as the top expected benefit, well ahead of budgetary savings (10%) and reduced risk (8%). 

The leaders furthest along with AI sort each use case by its value and how hard it is to govern. Most start with easier-to-govern work such as review and approval cycles, pre-call preparation, insight logging, triage, and coaching. With two-thirds already running AI projects, attention is turning to harder work: connecting systems, supporting a full product launch, and chaining multiple agents together. An agent supporting a field rep or medical science liaison has to work across many systems and with the AI agents already built into each one. That raises new questions about what to trust and who answers for the result. 

People remain the hardest part of adoption. The issue of change management was a common challenge raised at every roundtable. Asked which skill humans most need to keep, 45% chose judgment, followed by human connection (31%) and strategy (24%). The report recommends redrawing roles in detail, separating what an AI agent handles from what the human keeps. 

Introducing a Common Standard for Trust: The RAIL Score 

To give the industry a shared bar, the RAIL Score provides a rubric that grades any agentic AI system on six components of responsible AI, including governance, security, testing and certification, human centricity, value creation, and orchestration. Each component is scored “high” and trustworthy enough for use in life sciences, “medium” with specific gaps to close first, and “low” and not fit for use. The report also includes tools to put the score to work. These include a self-grading scorecard, a vendor-grading checklist, an AI agent job description template, and a 90-day launch checklist. 

“The industry has moved past whether to use agentic AI. Leaders now want to know which systems they can trust enough to scale, and today there’s no shared bar to answer that,” said Parth Khanna, co-founder and CEO of ACTO. “Any agentic AI system has to get security and governance right. The RAIL Score gives teams a consistent way to grade systems against the standard a regulated industry demands, so trust can rest on evidence instead of vendor claims.” 

Methodology 

The Responsible AI in Life Sciences (RAIL) Report 2026 draws on eight in-person executive roundtables with 80 senior leaders across North America and Europe, held February through April 2026, as well as an online survey of 135 leaders at pharmaceutical, biotech, and medical device companies, fielded June 8 through July 17, 2026. Nearly all survey respondents (97%) hold director-level roles or above across commercial, medical affairs, legal and compliance, learning and development, and marketing functions. 

The complimentary RAIL Report 2026 and related tools are available now at acto.com/RAIL. 

To hear more about the findings, register for the upcoming webinar, “Responsible AI in Life Sciences: What Leaders Say About Scaling Agentic AI,” on Wednesday, November 4 at 11:00am Eastern. 

About ACTO 

ACTO helps life sciences companies bring therapies to patients after regulatory approval. Its AI-powered Field Excellence Platform and AI SuperAgents speed product launches, strengthen field execution, and deepen customer engagement for commercial and medical teams. ACTO elevates training and coaching and agentifies up to 30% of the work in customer-facing roles. That frees reps, medical science liaisons, and their leaders to focus on human connection, judgment, and strategic execution. Fourteen of the top 50 pharmaceutical companies use ACTO, along with high-growth biotechs and leading medtech organizations. ACTO is FDA 21 CFR Part 11 validated, SOC 2 Type II certified, and a Veeva Gold Product Partner. Learn more at 
www.acto.com. 

Research HighlightsResponsible AI in Life Sciences (RAIL) Report 2026 

The RAIL Report 2026 draws on eight executive roundtables with 80 senior leaders across North America and Europe and an online survey of 135 leaders at pharmaceutical, biotech, and medical device companies. Nearly all respondents (97%) are director level or above. The research examines how life sciences organizations evaluate, govern, and scale agentic AI in commercialization. 

Governance Is the Defining Issue 

Trust May Be the Real Barrier to Scale 

From Where to Start to What to Build Next 

Barriers Are Organizational 

The RAIL Score 

The complimentary RAIL Report 2026 and related tools are available now at acto.com/RAIL. 

To hear more about the findings, register for the upcoming webinar, “Responsible AI in Life Sciences: What Leaders Say About Scaling Agentic AI,” on Wednesday, November 4 at 11:00am Eastern. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/industry-report-shows-64-of-life-sciences-leaders-taking-action-to-establish-ai-governance-302921671.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support 

PITTSBURGH, Oct. 28, 2026 /PRNewswire/ — Today, MolecuLight announces that it has received Frost & Sullivan’s 2026 Global Company of the Year Award in the wound imaging industry. The recognition highlights MolecuLight’s leadership in advancing objective wound assessment, its clinical evidence supporting improved patient outcomes, and its comprehensive training and customer support. 

Frost & Sullivan’s assessment recognizes MolecuLight’s ability to bring bacterial fluorescence imaging including location of bacteria and load, digital wound measurement, and thermal imaging together in a handheld platform. These capabilities help clinicians locate elevated bacterial burden that may be missed during visual assessment, accurately track changes in wound size, and make more informed treatment decisions. EHR connectivity further supports efficient documentation and continuity of care. MolecuLight’s SOC 2 Type II and FIPS certifications reinforce its commitment to secure clinical documentation and robust cybersecurity. 

The report also highlights clinical evidence supporting improved wound healing, reduced antibiotic use, and fewer infection complications with fluorescence-guided care, alongside MolecuLight’s commitment to helping clinical teams use the technology effectively. 

“This recognition reflects our commitment to giving clinicians objective information that helps them improve care for patients with wounds,” said Anil Amlani, Chief Executive Officer of MolecuLight. “By combining clinically validated imaging with practical workflows, education, training, and ongoing support, we help care teams translate that information into treatment decisions that support better healing.” 

Frost & Sullivan’s Company of the Year recognition evaluates organizations across innovation, performance, and customer impact. 

To learn more about Frost & Sullivan’s assessment of MolecuLight, view the full report. 

About MolecuLight 

MolecuLight is a privately held medical imaging company with a global footprint, dedicated to manufacturing and commercializing point-of-care wound imaging devices. Its FDA-cleared MolecuLight i:X® and DX® systems provide real-time detection of elevated bacterial burden and accurate digital wound measurement. MolecuLightDX+® additionally offers thermal imaging. The technologies’ effectiveness and clinical utility are supported by more than 100 peer-reviewed publications. 

About Frost & Sullivan 

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards. 

For sales, media or other inquiries or further information, please contact: MolecuLight, Danielle Dunham, Director of Product and Marketing, T. +1.416.542.5524, ddunham@moleculight.com, www.moleculight.com
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/moleculight-named-frost–sullivans-2026-global-company-of-the-year-in-wound-imaging-302921291.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

HO CHI MINH CITY, Vietnam, Oct. 28, 2026 /PRNewswire/ — Mia Saigon has been awarded One MICHELIN Key in the 2026 MICHELIN Guide hotel selection, joining 21 hotels in Vietnam, and only three in Ho Chi Minh City, to hold the distinction. 

Introduced in 2024 as the hotel equivalent of the MICHELIN Star, the Key is awarded after anonymous stays by MICHELIN Inspectors, who assess architecture and interior design, the quality and consistency of service, personality and character, value, and a hotel’s contribution to its setting. Hotels cannot apply for it. Worldwide, 2,832 hotels now hold a Key. 

The recognition stands out in a selection led largely by international hotel groups. Mia Saigon is owned, led and run by Vietnamese people, and forms part of Mia Luxury Collection, a homegrown group of boutique properties. 

“Mia Saigon was created as a home by the river, where every guest is known by name,” said Ms Trinh Tran, Hotel Manager. “As a Vietnamese team, we bring the warmth of our hospitality to every stay. We are honoured that the MICHELIN Guide has recognised that spirit.” 

Guests may arrive by the hotel’s shuttle boat along the Saigon River rather than by road. What greets them is a 53-room house drawing on Indochine design and the romance of Saigon’s Art Deco era, where rooms and suites take their palettes from four gemstones – Citrine, Ruby, Sapphire and Emerald – and each opens onto a private balcony above the river or the gardens. 

Art gives the house its character. Vietnamese fine art is placed throughout, from the riverside lobby to the rooftop, among it works by Bùi Xuân Phái and Đỗ Xuân Doãn, Chu Đậu pottery and ancient ceramics, the oldest some 2,000 years old. Each guest floor then carries a collection of its own, drawn from the everyday objects of 20th-century Vietnam: hand-painted propaganda posters that never went to print, book covers, stamps, matchbox art, first day covers and magazines. Guests can follow the whole collection on the hotel’s own art tour. 

The house gathers around The Living Room, known for its afternoon high tea, while Kitchen by the River serves refined Vietnamese and international cuisine and The Muse pours artisanal cocktails and tapas. Ô Spa, a riverside pool and lush gardens complete the retreat. 

Reservations are available at miasaigon.com. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/mia-saigon-awarded-one-michelin-key-as-vietnamese-run-hospitality-joins-the-global-stage-302922129.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

TORONTO, Oct. 28, 2026 /PRNewswire/ — Transpharmation Ltd., a science-led global leader in neuroscience, pain and metabolic disease preclinical contract research, is pleased to announce its acquisition of OrganoTherapeutics SARL, a leader in patient-derived organoid technologies that advance the discovery and development of novel therapies for neurodegenerative/ CNS disorders. 

Following decades of slow progress, discovery in the neurodegenerative space has entered a new era. Our understanding and treatment of debilitating diseases such as Alzheimer’s and Parkinson’s is rapidly transforming as we are seeing worldwide breakthroughs in genetics, biomarkers, patient-derived cellular models, organoids and translational neuroscience. 

Commenting on the acquisition, Dr. Mark Duxon, CEO of Transpharmation Ltd., stated: “Transpharmation has built a reputation for translational in vivo pharmacology over the last 25 years. With the acquisition of OrganoTherapeutics we are taking our first step in the fulfilment of our ambition to build translational CRO services that include human tissues and systems. We see a clear future for the business in the provision of non-animal models alongside our preclinical pharmacology. Drug discovery requires better prediction of drug action and efficacy prior to clinical trials. We believe that being at the forefront of patient-derived 3D organoid work, particularly in the Neurology space, will help provide our clients with increased confidence in their molecules and targets.” 

OrganoTherapeutics will continue to operate as a subsidiary of Transpharmation Ltd., with a seamless transition fostering collaboration to amplify the strength of both organizations. The Co-Founder of OrganoTherapeutics, Dr. Jens Schwamborn, responded by saying: “Joining Transpharmation is a logical next step for OrganoTherapeutics. Over the last few years, we have built human iPSC-derived brain organoid and assembloid models for Parkinson’s, Huntington’s, ALS and other neurodegenerative diseases, and we have used them in many studies for pharma and biotech partners. Together with Transpharmation’s long experience in translational in vivo pharmacology, we can now offer clients both approaches under one roof and help them to take better decisions earlier in drug development.” 

Through the acquisition, Transpharmation and OrganoTherapeutics will bring together complementary expertise in translational neuroscience and human stem cell-derived organoid technology. The combined capabilities will enable biopharma sponsors to investigate disease biology, validate targets and evaluate novel therapeutics using both advanced human-relevant models and established translational research platforms. By integrating these approaches, Transpharmation aims to provide a more predictive path from discovery to development and help accelerate innovation in neurodegenerative disease research. 

As researchers gain access to more predictive human-relevant systems and vast biological insights, discoveries are emerging at an increasingly rapid pace. The therapeutic landscape for these areas is in active transformation, and a large team of organoid and neurodegenerative disease experts with a breadth of knowledge in the field provides ideal toolkit for researchers. 

About Human Stem Cell-Derived Brain Organoids 

Brain organoids are miniature, lab-grown models of human brain tissue made from stem cells donated by healthy volunteers or patients. They contain many of the brain’s key cell types, so scientists can study brain diseases such as Parkinson’s in real human cells and test promising new treatments more effectively before clinical trials. 

Luxembourg-based OrganoTherapeutics specializes in patient-specific midbrain organoid and assembloid models of Parkinson’s, Huntington’s, ALS and other neurodegenerative diseases developed from its own research. 

About Human-Relevant Models in Neurodegenerative Disease Research  

Neurodegenerative diseases such as Parkinson’s, Alzheimer’s and ALS slowly damage nerve cells in the brain and spinal cord. 

Very few treatments can slow them down, and many medicines that looked promising in early lab work have failed once they reached patients. One reason is that traditional research models, such as animals or simple flat layers of cells, don’t fully capture how these diseases behave in the human brain. 

Human-relevant models help close that gap. Brain organoids are grown from human stem cells, sometimes from a patient’s own cells, so researchers can study disease in living human tissue. 

When these models are combined with established preclinical approaches, scientists get a clearer picture of how a potential treatment is likely to work in people. That can help researchers make better decisions earlier, cut down on costly late-stage failures, and bring effective therapies to patients sooner. 

About OrganoTherapeutics 

OrganoTherapeutics is a Luxembourg based company that develops and applies human iPSC derived brain organoid and assembloid models for drug discovery in neurological diseases. Founded as a spin-off of the University of Luxembourg, the company works with pharmaceutical and biotech partners. Its midbrain, striatal, cortical and hindbrain models are generated from patient derived and genetically engineered cell lines and reproduce key features of human disease, such as the vulnerability of dopaminergic neurons and the formation of neuromelanin in Parkinson’s disease. Beyond Parkinson’s disease, OrganoTherapeutics runs programs in Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal dementia and a range of rare neurological disorders. Its studies cover the full path from model generation and compound testing to imaging, electrophysiology, omics and machine learning-based data analysis. 

About Transpharmation 

Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. Our clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology throughout our preclinical services. Transpharmation has a strong focus on preclinical evaluation of potential CNS therapeutics including the areas of epilepsy, pain, neurodegeneration, depression, anxiety, schizophrenia and cognition. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/transpharmation-ltd-announces-strategic-acquisition-of-organotherapeutics-sarl-302921332.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

With 644% revenue growth and more than 4,200 applications supported worldwide, Apera AI is moving vision-guided robotics from custom projects to scalable products with its VuePod turnkey smart cell and ForgeAR augmented reality app. 

VANCOUVER, BC, Oct. 28, 2026 /PRNewswire/ — Apera AI has been recognized by Deloitte’s 2026 Technology Fast 50™
 awards program for its rapid growth, entrepreneurial spirit, and bold innovation. It is the second consecutive year the vision-guided robotics company has been named to the list, following its 10th-place ranking in 2025. 

Apera AI’s CEO, Sina Afrooze, credits the company’s patented 4D Vision technology, and its shift from custom integration projects to turnkey products like VuePod, with the company’s impressive growth. Afrooze said, “Being named a Deloitte Technology Fast 50 winner for the second year in a row belongs to our customers and partners, who trusted us to put 4D Vision into production on their plant floors. Thank you to every manufacturer, integrator, and partner who has grown with us. Your feedback shaped VuePod, and your success drives everything we build.” 

The program recognizes Canada’s 50 fastest-growing technology companies based on the highest revenue growth percentage over the past four years. Apera AI ranks 37th with 644% revenue growth from 2022 to 2025. 

“The 2026 Technology Fast 50 winners exemplify the ingenuity, resilience, and ambition that continue to define Canada’s technology sector,” said Brendan Cooper, National Technology Fast 50 program co-leader. “We are proud to celebrate their achievements and recognize the meaningful impact they are making in communities and markets across the country.” 

Apera AI’s 4D Vision now supports more than 4,200 applications globally, at six of the world’s top 10 automotive OEMs, Tier 1 and Tier 2 suppliers, and manufacturers in pharmaceuticals, food and beverage, and data center supply. Apera’s growth is built on real, deployed solutions, not pilots and have given the company a deep understanding of the hard, unpredictable problems robots face on actual plant floors. 

Apera AI has also achieved SOC 2 Type II compliance in accordance with the American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations, also known as SSAE 18. The independent audit, conducted by Prescient Security, confirms that Apera’s security and data protection controls operate effectively over time, a growing requirement as 4D Vision runs inside the production environments of the world’s largest manufacturers. The milestone reflects Apera’s ongoing commitment to protecting customer data and meeting the standards enterprise manufacturers expect from their automation partners. 

VuePod: vision-guided turnkey bin-picking smart cell 

Launched at Automate 2026 in June, VuePod packages what Apera has learned from thousands of applications in live production into a complete, self-contained bin-picking smart cell, built on 4D Vision and delivered in partnership with Ethos Automation. Each cell is validated in simulation on the customer’s part profile before it ships, so on-site setup comes down to three steps (connect, calibrate, and teach placement) with no robot programming or vision expertise required. That simplicity is the point: VuePod is the first step toward agentic physical AI automation systems that are as easy to teach and install as a person. 

Because every VuePod shares the same design, setup procedure, and support model, vision assets and robot programs carry over and each additional station deploys faster than the last. That repeatability is shifting vision-guided robotics from one-off integrations toward scalable deployment, turning automation from a single high-risk project into a program manufacturers can expand across lines and plants as they face persistent labor shortages, rising costs, and tighter margins. It also leaves Apera well-positioned to win as physical AI, embodied AI, and agentic AI move from the lab into the factory, where success depends on solving hard, real-world problems at scale. 

Manufacturers can explore VuePod on its new website, launching today: https://apera.ai/vuepod/
 

ForgeAR: see VuePod on your floor before it ships 

Apera AI is also bringing its Forge platform onto the factory floor with ForgeAR, an augmented reality app that places a full-scale, pre-configured VuePod (robot, gripper, cameras, bins, and safety systems) exactly where it will run. ForgeAR is another step in bringing the digital world closer to the physical world and making new automation easy and intuitive to deploy. Plant managers, automation engineers, and integrators can walk around the cell, check clearances, and confirm the robot can reach downstream equipment before the cell is built. The latest release adds more than 10 new VuePod configurations, including 3×3 ft bins for smaller spaces and dual end-of-arm tooling for long parts. 

ForgeAR is a free download on the App Store for iPhone Pro: https://apps.apple.com/ca/app/forgear/id6781779296
 

“Vision-guided robotics has been held back by custom projects that take months to design and are hard to repeat,” added Afrooze. “VuePod uses agentic physical AI to plan and correct every pick on its own, so manufacturers can deploy one proven cell, then the next ten, with the same results. That is how automation ROI scales, and how manufacturers keep their lines running through the labor shortage.” 

To qualify for the Deloitte Technology Fast 50 ranking, companies must have been in business for at least four years, have a minimum revenue of $50,000 in 2022 and $5 million in 2025, be headquartered in Canada, own proprietary technology, and invest a minimum of 5% of gross revenues in R&D activities that are conducted in Canada. 

“This year’s winners demonstrate what is possible when vision, talent, and innovation come together. They are tackling complex challenges, unlocking new opportunities, and fueling growth across Canada’s technology ecosystem,” said Amanda Perran, National Technology Fast 50 program co-leader. “Their success is inspiring the next generation of entrepreneurs and helping to build a more connected, competitive, and innovative future for Canada.” 

Deloitte’s Technology Fast 50 program winners consist of public and private companies in the technology sector that are transforming the industry. The program runs alongside the broader Deloitte North American Technology Fast 500™, and winners are automatically eligible for this elite ranking. 

About the Deloitte Technology Fast 50 program 

The Technology Fast 50 program is Canada’s pre-eminent technology awards program. It recognizes business growth, innovation, and entrepreneurship in three distinct categories: Technology Fast 50, Enterprise—Industry Leaders, and Companies-to-Watch. The program also recognizes thriving technology companies in the United States and Canada in partnership with the North American Technology Fast 500 program. Program sponsors for 2026 include RBCx, NRF, TMX, EDC, CCI, Lafond, and The Globe and Mail. For more information, visit www.fast50.ca. 

About Apera AI 

The pioneer in 4D vision for robotic automation, Apera AI makes factories more productive by empowering robots with human-like vision and advanced artificial intelligence, dramatically increasing speed, accuracy, and reliability. Its patented 4D Vision unlocks factory performance, enabling automotive OEMs, Tier 1 suppliers, and other industrial manufacturers to achieve unmatched levels of productivity, quality, and cost savings. Learn more at www.apera.ai. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/apera-ai-named-one-of-deloittes-2026-technology-fast-50-winners-for-the-second-consecutive-year-302920819.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

La notte tra il 31 ottobre e il primo novembre vedrà centinaia di aderenti all’associazione Templari Oggi riunirsi in preghiera simultanea lungo tutta la penisola. Mentre lo spazio pubblico e le cronache registrano la diffusione di celebrazioni legate a Halloween — periodo storicamente sfruttato anche per riti sacrileghi, profanazioni o deviazioni occulte —, l’associazione risponde sul piano strettamente spirituale attraverso turni di adorazione eucaristica, recita del Rosario e presidio dei luoghi di culto. 

L’iniziativa si inserisce nella vocazione dell’associazione di promozione sociale, da anni impegnata nella custodia, tutela e riapertura di edifici sacri altrimenti dimenticati o esposti al degrado. Nella notte del 31 ottobre, la risposta dei Templari Oggi non assume toni polemici né posture aggressive, ma si concretizza nella presenza fisica e orante all’interno delle chiese. L’obiettivo dichiarato è offrire un argine spirituale fondato sulla disciplina, sul silenzio e sull’adorazione a tutela della sacralità degli altari, opponendo la luce della tradizione cristiana a qualsiasi richiamo dell’occultismo. 

La mobilitazione interesserà oltre trenta centri urbani in maniera coordinata. Gli incontri di preghiera si terranno a Roma, Torino, Milano, Bologna, Siena, Modena, Reggio Emilia, Pistoia, Ancona, L’Aquila, Chieti, Bari, Trani, Lecce, Taranto, Udine, Gorizia, Venezia, Padova, Verona, Rovigo, Bolzano, Mantova, Ferrara, Assisi, Imola, Ravenna, Caserta, Napoli, Messina, Agrigento, Palermo, Catania e Sassoferrato. In ciascuna di queste realtà territoriali, i membri dell’associazione garantiranno un servizio orante e discreto. L’impegno ribadisce i cardini operativi della realtà contemporanea: testimonianza di fede dentro la Chiesa, servizio alla comunità ecclesiale e presidio continuativo dei templi sacri. 

La mobilitazione oltrepassa i confini della penisola italiana, assumendo una dimensione globale coordinata attraverso la rete internazionale dell’associazione. Nella stessa notte, la veglia di adorazione e testimonianza vedrà presidi attivi nelle Americhe, con adesioni documentate negli Stati Uniti, in Canada e in Brasile. Sul quadrante europeo, turni di preghiera si terranno in Spagna, Francia, Germania, Regno Unito, Austria e Svizzera. La presenza orante raggiungerà infine l’Asia e l’Oceania, coinvolgendo comunità e referenti locali in Cina, Taiwan, Australia e Nuova Zelanda, a suggello di un’azione continuativa di custodia spirituale. 

Contatti:
KTP.Agency
emiliano.stampa@gmail.com
 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Responsabilità editoriale di KTP.Agency

—

immediapress

Le giallorosse conquistano un’altra vittoria nella quinta giornata di Serie A1. Ranalli e Rožić protagoniste con tre reti ciascuna. Sabato 31 ottobre la sfida europea contro il FTC Telekom Budapest.
 

Ostia, 26 ottobre 2026 – La SIS Roma supera il Sori Pool Beach per 19-11 al Polo Natatorio di Ostia nella quinta giornata del campionato di Serie A1 di pallanuoto femminile, confermando il momento positivo dopo la vittoria nel derby infrasettimanale contro la Lazio. 

La squadra allenata da Marco Capanna conduce l’incontro fin dalle prime battute, costruendo un vantaggio importante nei primi due tempi e amministrando il risultato nella seconda parte della gara. 

Partenza decisa della SIS Roma, che chiude il primo parziale avanti 7-4. Le giallorosse mantengono alta la pressione offensiva anche nel secondo tempo, imponendosi per 6-3 e raggiungendo l’intervallo lungo sul punteggio di 13-7. 

Nella ripresa la formazione capitolina continua a gestire il vantaggio, conquistando il terzo parziale per 4-3. Nell’ultima frazione il ritmo realizzativo diminuisce, ma la SIS Roma mantiene il controllo e chiude sul definitivo 19-11. 

Tra le protagoniste della vittoria spiccano Chiara Ranalli e Iva Rožić, entrambe autrici di tre gol. Due reti ciascuna per Zaplatina, Morrone, Kudella e Minuto. Completano il tabellino delle marcatrici Malluzzo, Picozzi, Bosveld, Cocchiere e Carosi. 

Nonostante il successo, il tecnico della SIS Roma Marco Capanna sottolinea la necessità di trovare maggiore continuità nel gioco, soprattutto in vista dei prossimi appuntamenti internazionali. 

«Giocando ogni tre giorni si possono vedere al massimo piccoli miglioramenti. In certi aspetti, contro un buon Sori, ci sono stati. In altri, che sono la priorità in questo momento, ancora no. Ora una settimana per preparare una bella e importante partita di Coppa contro il FTC», ha dichiarato l’allenatore. 

Archiviata la vittoria in campionato, la SIS Roma si prepara al prossimo impegno europeo. 

Sabato 31 ottobre 2026, alle ore 20:00, le giallorosse affronteranno il FTC Telekom Budapest nella prima partita della Champions League femminile 2026/27. 

Una sfida importante per la formazione capitolina, chiamata a dare continuità ai risultati e a migliorare gli aspetti di gioco evidenziati dal tecnico dopo il successo contro il Sori. 

SIS Roma – Sori Pool Beach 19-11
 

Parziali: 7-4, 6-3, 4-3, 2-1. 

SIS Roma: Sesena, Zaplatina 2, Morrone 2, Plotz, Ranalli 3, Malluzzo 1, Picozzi 1, Rožić 3, Kudella 2, Bosveld 1, A. Cocchiere 1, Carosi 1, Bottiglieri, Rossi, Minuto 2. Allenatore: Marco Capanna. 

Sori Pool Beach: Caso, T. Cocchiere 1, Gitto, Zanetta 2, Gallettini, Capurro, Casserly, Chiappini 6, Nesti, Ruani, Lombella 2, Santapaola, Zampini, Keszthelyi, Novella. Allenatore: Ivaldi. 

Arbitri: Paoletti e Giacchini. 

Contatti:
KTP.Agency
emiliano.stampa@gmail.com
 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE

Responsabilità editoriale di KTP.Agency

—

immediapress

WOLFSBURG, Germany, Oct. 28, 2026 /PRNewswire/ — Held biennially, the International Suppliers Fair (IZB) in Wolfsburg is one of Europe’s most influential automotive supply chain shows, running October 27–29. BICV Technology Co., Ltd. (hereinafter BICV), a leading Chinese supplier of intelligent connected vehicle solutions, debuts at IZB with over 20 products forming our full-stack innovative product portfolio, covering production-proven offerings and cutting-edge technologies. BICV showcases offerings spanning intelligent cockpit domain, cockpit-driving fusion, telematics and navigation products. 

At the show, BICV demonstrates its advanced technical strength via a refreshed lineup. Its new-generation high-end intelligent cockpit, optimized at the underlying layer, delivers low-latency multimodal AI interaction, smooth in-vehicle operation and immersive Dolby Vision spatial audio-visual experience, turning computing power into a stable, comfortable in-cabin mobility experience. The BDIPPER cockpit-driving fusion computing platform adopts the “One Platform Unifying Four Domains” architecture, linking computing pools for intelligent driving, cockpit domain, instrument cluster and vehicle control to support dynamic, scenario-based computing allocation. Its 3D AR-HUD leverages native spatial 3D display technology to break limits of traditional onboard flat screens, overlaying virtual and physical driving information to safeguard driving safety alongside immersive in-car 3D audio-visual experience. With full-stack capabilities from core components to system integration, BICV provides modular, customizable solutions from discrete components to domain controller platforms to meet OEMs’ diverse model demands. 

With over ten years in overseas markets, BICV has built a global integrated delivery system for R&D, manufacturing and technical support, with cumulative overseas shipments above one million units. It operates local development networks across Europe, North America and Southeast Asia, plus business and manufacturing hubs in Japan, Europe and Southeast Asia. Having forged deep ties with global leaders including Suzuki, Citroën, Proton, Pioneer and Alpine, BICV delivers one-stop services for overseas automakers via local teams, covering joint development, mass-production supply and after-sales support. 

As the global automotive industry transforms toward intelligent connectivity, BICV will continuously upgrade its global technical delivery capabilities. Drawing on local R&D and manufacturing capabilities, we deliver engineering-ready, mass-producible intelligent connected solutions for automakers across Europe and worldwide. BICV expects close collaboration with global supply chain partners for win-win outcomes, to enable inclusive smart mobility and redefine next-gen spatial intelligent mobility. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/going-global-with-intelligent-connectivity-expanding-into-europe–bicv-debuts-at-izb-2026-in-wolfsburg-302922036.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

Un’unica denominazione globale riflette le dimensioni del gruppo, le sue risorse finanziarie e le sue competenze negli investimenti nell’ecosistema globale delle infrastrutture digitali. 

BALA CYNWYD, Pennsylvania, 28 ottobre 2026 /PRNewswire/ — Radius Global Infrastructure, Inc. ha annunciato oggi che APWireless è diventata Radius Global Infrastructure, riunendo il gruppo sotto un unico nome a livello globale in grado di rifletterne le dimensioni, le competenze in materia di investimenti e il posizionamento nel settore delle infrastrutture digitali. Con oltre 14.000 contratti di leasing in 23 paesi, il gruppo è una realtà globale negli investimenti infrastrutturali, con un orizzonte di investimento e di creazione di valore di lungo termine e con un focus sull’acquisizione e la gestione di asset strategici che supportano un mondo sempre più connesso. 

A fronte dell’accelerazione della domanda di dati e di connettività e dell’evoluzione verso reti sempre più complesse, continua a crescere il fabbisogno di competenze di investimento specializzate, capitale flessibile e capacità di esecuzione globale. Radius Global Infrastructure investe nell’ecosistema digitale su diverse tipologie di infrastrutture: terreni/lastrici solari con installazione di antenne per la telefonia mobile, centrali telefoniche, punti di interconnessione, punti di aggregazione in fibra, sistemi per copertura indoor (DAS), data center e torri di telefonia mobile. L’ampiezza delle sue capacità di investimento consente al gruppo di operare trasversalmente su diverse tipologie di infrastrutture digitali e su diverse aree geografiche, fornendo a operatori di rete, TowerCo, proprietari di immobili e partner di infrastrutture digitali soluzioni di capitale supportate da una profonda competenza di settore ed esecuzione sul mercato locale. 

“La domanda di dati e connettività sta rimodellando l’infrastruttura da cui il mondo dipende, creando significative opportunità di investimento a lungo termine”, ha dichiarato Julian Plumstead, CEO di Radius Global Infrastructure. “Il nostro ruolo consiste nel fornire capitale, esperienza e portata globale in relazione agli asset che rendono possibile tale connettività. Operare con il nome Radius Global Infrastructure riflette l’entità di tale opportunità, così come le dimensioni e l’esperienza che portiamo nell’ecosistema globale delle infrastrutture digitali.” 

Dall’inizio delle sue attività, il gruppo ha investito oltre 3,4 miliardi di dollari in attività infrastrutturali strategiche, allocando capitali attraverso relazioni di lunga durata con proprietari, operatori e partner industriali in tutto il mondo. Il suo approccio di investimento combina la dimensione globale e le risorse di capitale con una profonda conoscenza dei mercati locali, una disciplina di esecuzione rigorosa e un orientamento a partnership di lungo termine. Insieme ai suoi partner, Radius Global Infrastructure mira a creare valore duraturo, sostenendo nel contempo i continui investimenti necessari per espandere ed evolvere le reti che supportano la connettività globale. 

A partire dal 28 ottobre 2026, gli uffici e le imprese del gruppo opereranno in tutto il mondo sotto il nome di Radius Global Infrastructure. La proprietà, la leadership e la struttura finanziaria del gruppo restano invariate: clienti e partner continueranno a lavorare con gli stessi team e punti di contatto. 

“L’esperienza e le relazioni su cui si basano i nostri clienti rimangono invariate”, ha aggiunto Plumstead. “Il nome Radius Global Infrastructure riflette il valore che portiamo in tali relazioni: dimensione globale, profonda esperienza negli investimenti e significativa disponibilità di capitale per perseguire eccitanti opportunità. Possediamo le risorse, l’esperienza e le capacità di esecuzione per investire insieme ai nostri partner e supportare l’infrastruttura necessaria per la prossima generazione di connettività globale.” 

Ulteriori informazioni su Radius Global Infrastructure sono disponibili su www.radiusglobal.com. 

Informazioni su Radius Global Infrastructure, Inc.Radius Global Infrastructure, Inc. (“Radius Global”) è una società leader mondiale nel settore delle telecomunicazioni e degli investimenti in infrastrutture digitali. Radius Global è specializzata nell’acquisizione e nella gestione di infrastrutture di telecomunicazioni strategiche, tra cui stazioni radio base, centrali di rete, punti di interconnessione, punti di aggregazione in fibra, sistemi di copertura indoor (DAS), data center e torri di telefonia mobile. Con oltre 14.000 contratti di leasing in 23 paesi, Radius Global è uno dei maggiori acquirenti immobiliari a livello globale. Radius Global è una società in portafoglio di EQT Active Core Infrastructure SCSp e del Public Sector Pension Investment Board. Ulteriori informazioni su Radius Global Infrastructure, Inc. sono disponibili su www.radiusglobal.com. 

Contatto per i media:Marlyn GarcíaVicepresidente, MarketingE-mail: media@radiusglobal.comTelefono: (619) 359-3925 

View original content to download multimedia:https://www.prnewswire.com/it/comunicati-stampa/con-il-passaggio-di-apwireless-sotto-un-unico-brand-di-gruppo-a-livello-globale-radius-global-infrastructure-scrive-un-nuovo-capitolo-negli-investimenti-in-infrastrutture-digitali-302921978.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle  

BERLIN, Oct. 28, 2026 /PRNewswire/ — Appian (Nasdaq: APPN) and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new offering automates clinical trial site identification and selection across therapeutic areas, indications, and geographies. 

The live solution is the first step in a shared vision by PSI and Appian to build a scalable platform that connects automation, AI-powered capabilities, and process orchestration across the full clinical trial lifecycle. Together, the companies are creating a foundation designed to improve efficiency, transparency, and speed across complex clinical trial processes. 

AI and process orchestration for complex site selectionClinical trial site selection is a highly coordinated process involving multiple stakeholders, large volumes of documentation, and parallel activities across countries and regions. The new solution brings previously manual, decentralised steps into a single digital process, from project initiation through the subsequent stages of site selection. 

Recognised by Gartner as a Leader in the 2026 Gartner® Magic Quadrant™ for Business Orchestration and Automation Technologies (BOAT), we believe the Appian Platform provides the foundation for this solution. It identifies and selects the most suitable study sites for sponsors, providing greater end-to-end visibility and enabling faster execution across the site selection process. 

The solution goes beyond task automation to orchestrate the end-to-end process, connecting people, data, systems, and AI in a single workflow. It coordinates activities across teams and geographies and automates information and document processing. It also manages routing and exceptions, providing real-time insight into process performance. 

The solution integrates with PSI’s core systems and data warehouse, as well as Appian’s AI and process intelligence capabilities. The integrated solution creates a scalable foundation for faster decisions, greater consistency, and continuous improvement. 

Starting point for a long-term platform strategyThe site selection solution puts PSI’s platform vision into practice. It combines PSI’s focus on predictable clinical trial delivery with Appian’s process automation and AI capabilities. 

“The AI-powered clinical trial site selection solution is an important step in how we are rethinking and connecting our operational processes,” says Kirill Soldatov, Head of Process Improvement at PSI. “PSI is known for our ability to deliver complex clinical trials on time. Building a more connected operational model through automation, AI-powered capabilities, and process orchestration within our existing workflows creates a scalable foundation for more predictable, accurate, and timely site selection worldwide, with the goal to further reduce or eliminate non-enrolling sites and patient enrollment delays.” 

“This initial project demonstrates the value AI can create when it is embedded in business processes. The solution helps PSI process information faster with automation and manage processes with greater transparency with orchestration. Through our strategic partnership with PSI, we aim to create a flexible, long-term foundation for further automation and innovation,” adds Alexander Motie, Regional Vice President DACH & Eastern Europe at Appian. 

With the first solution now live, PSI and Appian will build on this foundation by evaluating further use cases to extend AI-powered process orchestration across the clinical trial lifecycle. The goal is to shorten clinical studies and increase predictability, thus introducing new products to market and driving down costs for consumers. 

Find out how life sciences companies can use AI automation for faster speed to market here. 

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding future product capabilities, strategic plans, and industry growth, are forward-looking. These statements are subject to risks and uncertainties that could cause actual results to differ materially. Appian undertakes no obligation to update forward-looking statements. 

About PSI CROPSI is a global full-service contract research organisation (CRO), committed to being the best CRO in the world as measured by its customers, investigators, and vendors, and employees. PSI’s key operational differentiator is on-time delivery of clinical trials. This metric is still above 90% in 2026. 

The company specialises in pivotal clinical trials in oncology, gastroenterology, hematology, immunology, infectious diseases, neurology, among other indications. PSI provides expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies. 

In 2025, PSI celebrated its 30th year of business as the only fully independent and privately owned mid-sized CRO. PSI employs over 3,500 people across 58 countries as of September, 2026. 

Global headquarters are in Switzerland at 113a Baarerstrasse, Zug 6300. For more information, visit www.psi-cro.com. 

About AppianAppian provides AI automation for the most important business processes at the world’s largest organisations. 

On the Appian Platform, customers build AI-powered processes that accelerate work, reduce cost, and manage risk. Our platform is known for its unique power, reliability, and scale. We’ve been automating processes for more than 25 years and have proven expertise in enterprise operations. For more information, visit appian.com. [Nasdaq: APPN] 

Follow Appian DACH: LinkedIn, Youtube, Instagram, Facebook, and X. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/appian-and-psi-cro-form-strategic-partnership-to-advance-ai-driven-clinical-trial-operations-302921701.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

PARIS, Oct. 28, 2026 /PRNewswire/ — Geely Farizon unveiled the Farizon SV Model Year 2027 at Marché International de Rungis, the world’s premier fresh produce wholesale hub. A benchmark for European last‑mile delivery, Rungis demands dense multi‑drop routes, tight timetables and frequent stop‑start operation. The launch targets measurable operational benefits for fleets and independent operators, aligned with the More for Business proposition. 

First launched in France in April 2026, the Farizon SV is built on four pillars: capacity, efficiency, safety and comfort. The Model Year 2027 update solves real‑world fleet pain points to raise uptime and productivity. Built on Farizon’s purpose‑built native electric GXA‑M architecture, it features a modular chassis ready for flexible upfitting. It offers 13 m³ usable cargo volume and up to 384 km WLTP combined range. Its new CATL battery supports 2C DC charging from 20%–80% SOC in just 18 minutes. A new all‑wheel‑drive variant brings improved traction for wet roads, gradients and unpaved ground, suited to fresh produce and utility deliveries across Europe’s wet seasons. 

Ahead of the launch, local Rungis operators trailed the Farizon SV Model Year 2027 over full working days, simulating multi‑drop rounds and mid‑shift charging. One operator commented: “The SV’s cargo area works well with produce crates, and the low loading height makes repeated handling less tiring. Fast charging fits our lunch break, so we can top up without disrupting delivery schedules. It is a practical vehicle for our high‑intensity operation.” 

Marking a key milestone for Farizon’s European LCV range, the SV line‑up will expand with Combi and Minibus variants for chilled transport, conversions and passenger shuttles. The event included static displays, conversion demonstrators and on‑site test drives to demonstrate urban agility. Engineered around operator needs, the updated Farizon SV Model Year 2027 is a robust, job‑ready electric LCV, delivering on the More for Business promise for European fleet operators. 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/farizon-sv-model-year-2027-makes-its-french-debut-at-rungis-tested-for-real-world-delivery-302921894.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ — CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international medical aesthetics industry. 

SOLTOX is presented in 100 Unit and 200 Unit formulations with three defining technical characteristics: a 900 kDa toxin complex, a freeze dried dosage form, and an advanced purification process. Together, these attributes reflect a manufacturing approach emphasizing controlled processing, product characterization, and pharmaceutical quality. 

The 900 kDa complex describes the molecular size of the botulinum toxin protein complex, including associated proteins. This characteristic identifies a specific formulation feature rather than establishing any claim of superior clinical duration or efficacy. SOLTOX is supplied as a lyophilized powder intended for reconstitution before administration by qualified medical professionals, in accordance with applicable product labeling and local requirements. 

Purification forms another central element of the SOLTOX manufacturing approach. Advanced Botulinum Toxin Purification Technology is applied during the processing of botulinum toxin type A, with emphasis on separating the desired substance from unwanted materials. Production also involves controlled manufacturing conditions and botulinum toxin quality control procedures covering preparation, filling, freeze drying, and batch assessment. 

CELSET highlights these manufacturing characteristics as the technical foundation of SOLTOX. Its product positioning draws attention to formulation identity and process controls without equating manufacturing characteristics with unverified differences in patient outcomes. The brand combines technical information with a concise identity designed for recognition throughout the medical aesthetics sector. 

The launch establishes SOLTOX within CELSET’s international medical aesthetics activities. Its positioning reflects the growing visibility of Korean biotechnology and medical aesthetics manufacturing, alongside the importance of established medical channels and market specific regulatory frameworks. CELSET views country level market development and professional relationships as integral to the international presence of the SOLTOX brand. 

SOLTOX’s introduction broadens CELSET’s medical aesthetics portfolio, complementing its focus on scientifically grounded product communication. The company emphasizes a consistent brand presentation and clear information for healthcare professionals across different markets. Availability and use are governed by the regulatory requirements applicable in each country. 

About CELSET INC. 

Based in Seoul, South Korea, CELSET INC. is a Korean biotechnology company focused on the medical aesthetics sector. SOLTOX reflects the company’s commitment to distinctive brands, aesthetic medicine manufacturing principles, and professional communication for the global aesthetics industry. 

For inquiries:contact@celset.co.krHome Page : https://celset-aesthetics.com/
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/celset-launches-soltox-a-korean-botulinum-toxin-type-a-brand-for-international-markets-302921881.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire

ATHENS, Oct. 28, 2026 /PRNewswire/ — Greek and Serbian business leaders and tourism professionals will meet at the InterContinental Athenaeum Athens on 29 October to explore partnerships ahead of EXPO 2027 Belgrade, the first Specialised Expo in the Western Balkans. 

Part of EXPO’s international roadshow, the event will open with a press conference featuring Igor Kovačević, Chief Operating Officer and Director of the International Participants Department at EXPO 2027 Belgrade, and Dimitrios Skaikos, Greece’s Section Commissioner General. 

Presentations, a panel discussion and Q&A will explore participation and commercial opportunities. B2B speed-networking sessions will connect tourism professionals with Serbian partners to develop travel programmes combining EXPO visits with wider experiences across Serbia. 

“For Serbia, it is a natural partner in building cultural and business bridges and strengthening the ties that will help welcome the world to Belgrade for EXPO 2027,” said Kovačević. 

According to Serbia’s Ministry of Internal and Foreign Trade, bilateral trade in goods reached €884 million in 2025, while services trade totalled approximately €1.27 billion. 

Event details 

About EXPO 2027 Belgrade 

Taking place from 15 May to 15 August 2027 under the theme “Play for Humanity: Sport and Music for All”, EXPO 2027 Belgrade expects more than 140 international participants and around four million visits over 93 days. More than 250 bilateral business events and over 50,000 business meetings are planned in connection with EXPO 2027. 

Press contact: expo.serbia@mcgroup.com  

View original content:https://www.prnewswire.co.uk/news-releases/expo-2027-belgrade-to-connect-greek-and-serbian-tourism-and-business-professionals-in-athens-302921136.html
 

Copyright 2026 PR Newswire. All Rights Reserved. 

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi

—

immediapress/pr-newswire